Search Results - Richard A. Hubner
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis by Mairéad G. McNamara, Melissa Frizziero, Timothy Jacobs, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Eitan Amir
Published in Therapeutic Advances in Medical Oncology (2020-04-01)Get full text
Article -
6
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. by Angela Lamarca, Salvatore Galdy, Jorge Barriuso, Sharzad Moghadam, Elizabeth Beckett, Jane Rogan, Alison Backen, Catherine Billington, Mairéad G McNamara, Richard A Hubner, Angela Cramer, Juan W Valle
Published in PLoS ONE (2018-01-01)Get full text
Article -
7
Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Di... by Angela Lamarca, Richard A Hubner, Zainul Abedin Kapacee, Juan W Valle, Mairéad G McNamara, Lindsay E Carnie, Kate Vaughan, Lynne McCallum, Alison Backen, Jorge Barriuso, Marc Abraham
Published in BMJ Open (2021-05-01)Get full text
Article -
8
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroen... by Mairéad G. McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Jonathan Wadsley, Carys Morgan, Lucy R. Wall, Ian Chau, Nick Reed, Debashis Sarker, Jane Margetts, Daniel Krell, Judith Cave, Sharmila Sothi, Alan Anthoney, Christopher Bell, Alkesh Patel, Jamie B. Oughton, David A. Cairns, Wasat Mansoor, Angela Lamarca, Richard A. Hubner, Juan W. Valle
Published in EClinicalMedicine (2023-06-01)Get full text
Article
